Author:
Wu Wenbing,Cheng Ying,Zhou Hong,Sun Changzhen,Zhang Shujun
Abstract
AbstractCoronavirus disease 2019 (COVID-19) continues to take a heavy toll on personal health, healthcare systems, and economies around the globe. Scientists are expending tremendous effort to develop diagnostic technologies for detecting positive infections within the shortest possible time, and vaccines and drugs specifically for the prevention and treatment of COVID-19 disease. At the same time, emerging novel variants have raised serious concerns about vaccine efficacy. The SARS-CoV-2 nucleocapsid (N) protein plays an important role in the coronavirus life cycle, and participates in various vital activities after virus invasion. It has attracted a large amount of attention for vaccine and drug development. Here, we summarize the latest research of the N protein, including its role in the SARS-CoV-2 life cycle, structure and function, and post-translational modifications in addition to its involvement in liquid–liquid phase separation (LLPS) and use as a basis for the development of vaccines and diagnostic techniques.
Funder
the College Student Innovation and Entrepreneurship Training Program
the Natural Science Foundation of Southwest Medical University
the Natural Science Foundation of Luzhou
the Natural Science Foundation of Sichuan
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference201 articles.
1. Szekely J, Mongkolprasert J, Jeayodae N, Senorit C, Chaimuti P, Swangphon P, et al. Development, analytical, and clinical evaluation of rapid immunochromatographic antigen test for SARS-CoV-2 variants detection. Diagnostics (Basel). 2022;12:381.
2. Suthar TR, Gaikwad ST, Suthar AD. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): a review. Int J Curr Microbiol Appl Sci. 2020;9:3201–8.
3. Ma W, Yang J, Fu H, Su C, Yu C, Wang Q, et al. Genomic perspectives on the emerging SARS-CoV-2 omicron variant. Genomics Proteomics Bioinform. 2019. https://doi.org/10.1016/j.gpb.2022.01.001.
4. Aleem A, Samad ABA, Slenker AK. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). In: StatPearls. Treasure Island, StatPearls Publishing ; 2022.
5. Mohapatra RK, Kandi V, Verma S, Dhama K. Challenges of the Omicron (B.1.1.529) variant and its lineages: a global perspective. ChemBioChem. 2022;23:e202200059.
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献